Study is first to demonstrate how one specific combinational therapy may provide measurable benefits to patients with mitochondrial respiratory chain disorders, which currently lack FDA-approved therapies.

CHOP researchers describe different types of rashes they have seen in patients diagnosed with the COVID-19-related inflammatory syndrome.

CHOP Researchers identify genetic differences in certain neuron subtypes that may affect proper bowel function.

New findings from the latest MOMS2 analysis show prenatal repair of the spinal column confers physical gains that extend into childhood.

CHOP researchers found 100% of patients with negative COVID-19 tests up to three days before surgery were also negative at the time of surgery.

Early research shows how mild defects in the “batteries” of cells in brain tissue can lead to behaviors similar to those of autism.

Crash-involved autistic drivers were half as likely to crash due to speeding, but more than three times more likely to crash when making a left- or U-turn, suggesting need for tailored training

CHOP researchers have developed a gene therapy vector for sickle cell disease and other blood disorder that is potentially superior to competitors.

Subtle differences in recovery times were seen in certain subgroups, but unexpected findings could indicate a path forward with more equitable allocation of health resources.

CHOP researchers have found that skin-to-skin care can support mothers and their critically ill infants who have critical congenital heart disease.